Form 4: Hims & Hers Health Chief Commercial Officer Executes Stock Option and Sells Shares

Michael Chi, Chief Commercial Officer of Hims & Hers Health, exercised stock options and sold a portion of the acquired shares on December 2, 2024, under a pre-arranged trading plan.

Summary

• Michael Chi, the Chief Commercial Officer of Hims & Hers Health, executed a stock option to purchase 2,054 shares of Class A Common Stock at a price of $11.53 per share on December 2, 2024.
• On the same day, Mr. Chi sold 2,054 shares of Class A Common Stock at a price of $33.56 per share.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on March 1, 2024.
• Following these transactions, Mr. Chi directly owns 184,947 shares of Class A Common Stock and 55,465 stock options.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing stock transactions by an executive, which is neither positive nor negative in itself. It is a neutral event.

Industry Context

This is a routine filing related to executive stock transactions and is common for publicly traded companies. It provides transparency into the trading activities of company insiders.

Comparison to Industry Standards

• The use of a Rule 10b5-1 trading plan is a standard practice for executives to avoid accusations of insider trading.
• The vesting schedule of the stock options is typical for executive compensation packages in the tech and healthcare industries.
• The reported transactions are similar to those of other executives in comparable publicly traded companies.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation and trading activity.

Key Dates

Keywords

Hims & Hers Health, stock options, insider trading, Rule 10b5-1, executive compensation, Class A Common Stock, SEC Form 4, Michael Chi